<DOC>
	<DOCNO>NCT02097069</DOCNO>
	<brief_summary>The investigator aim compare effect different inositol stereoisomers supplementation lower insulin resistance level 8 week treatment pregnant woman GDM prevent adverse obstetric outcome . The study population include 80 woman GDM , randomly allocate subgroup A ( folic acid 400 mcg/day ) , subgroup B ( myo-inositol 2000 mg twice day ) , subgroup C ( D-chiro-inositol 250 mg twice day ) , subgroup D ( Myo-inositol plus D-chiro-inositol 550mg/13,8 mg twice day ) . Folic acid inositol stereoisomers administer start enrol time ( 24-28 week gestation , GDM diagnosis ) till delivery . The homeostasis model assessment insulin resistance ( HOMA-IR ) sensitivity index ( QUICKI ) check moment diagnostic oral glucose tolerance test ( 24-28 week ) 8 week treatment . Obstetric outcomes , rate woman need insulin therapy insulin dosage register .</brief_summary>
	<brief_title>Inositol Stereoisomers Treat Gestational Diabetes</brief_title>
	<detailed_description>Gestational diabetes mellitus ( GDM ) define carbohydrate intolerance begin first recognize pregnancy ( 1 ) . It characterize increase physiological insulin resistance associate increase risk perinatal maternal morbidity ( 2,3 ) . Inositol six-carbon polyol , normally present variety food , classify insulin sensitize agent . It exist nine different isomer include myo-inositol ( MI ) D-chiro-inositol ( DCI ) represent human body . Myo-inositol D-chiro-inositol glycans administration report exert beneficial effect metabolic , hormonal ovarian level ( 4-5 ) . Recently demonstrate Myo-inositol supplementation improve insulin resistance patient GDM ( 6 ) , whereas n't data use D-chiro-inositol Myo-inositol plus D-chiro-inositol woman affect GDM . In proposed study , investigator aim compare effect different inositol stereoisomers supplementation ( Myo-inositol , D-chiro-inositol Myo-inositol plus D-chiro-inositol ) lower insulin resistance level 8 week treatment pregnant woman GDM prevent adverse obstetric outcome . All available inositol formulation also contain folic acid ( 200 mcg ) . The study population include 80 woman GDM , randomly allocate subgroup A ( folic acid 400 mcg/day ) , subgroup B ( myo-inositol 2000 mg twice day ) , subgroup C ( D-chiro-inositol 250 mg twice day ) , subgroup D ( Myo-inositol plus D-chiro-inositol 550mg/13,8 mg twice day ) . Dietary control , folic acid inositol stereoisomers administer start enrol time ( 24-28 week gestation , GDM diagnosis ) till delivery . The homeostasis model assessment insulin resistance ( HOMA-IR ) sensitivity index ( QUICKI ) check moment diagnostic oral glucose tolerance test ( 24-28 week ) 8 week treatment . Obstetric outcomes , rate woman need insulin therapy insulin dosage register .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Gestational Diabetes diagnose within 2428 week gestation Caucasian pregnant woman Prepregnancy diabetes Nonsingleton pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Gestational diabetes mellitus</keyword>
	<keyword>Myo-inositol</keyword>
	<keyword>D-chiro-inositol</keyword>
	<keyword>Insulin resistance</keyword>
</DOC>